Most-cited papers on confirm follow versus cost musculoskeletal

Ranked by citation count via OpenAlex. Citations update on a rolling basis; list regenerates every 24h.

1. Extended Follow-up of ALPINE Randomized Phase 3 Study Confirms Sustained Superior Progression-Free Survival of Zanubrutinib Versus Ibrutinib for Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (R/R CLL/SLL)

   2023 · Blood · Brown, Jennifer R., Eichhorst, Barbara, Lamanna, Nicole et al.

   23 cited

2. Graft-Versus-Host Disease (Gvhd) Prophylaxis with Tacrolimus and Mycophenolate Mofetil (MMF) in 131 Matched Sibling Nonmyeloablative (NMA) Transplant Recipients: Long-Term Follow-up Confirms Extremely Low Incidence of Acute (a) Gvhd, High Incidence of Extensive Chronic (c) Gvhd and Favorable Disease Outcome.

   2008 · Blood · Sabry, Waleed, Labbé, Annie‐Claude, Blanc, Richard Le et al.

   6 cited